Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank29
3Y CAGR-53.5%
5Y CAGR-28.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-53.5%/yr
vs +41.8%/yr prior
5Y CAGR
-28.0%/yr
Recent deceleration
Acceleration
-95.3pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.24M | -2.1% |
| 2024 | $1.27M | +38.9% |
| 2023 | $915000.00 | -92.6% |
| 2022 | $12.36M | -57.6% |
| 2021 | $29.13M | +353.9% |
| 2020 | $6.42M | +83.8% |
| 2019 | $3.49M | +14.3% |
| 2018 | $3.06M | -8.5% |
| 2017 | $3.34M | +34.2% |
| 2016 | $2.49M | - |